Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
-
NHBE - Human Bronchial/Tracheal Epithelial Cells for B-ALITM CultureCatalog #: CC-2540S
Cryopreserved Normal Human Bronchial Epithelial (NHBE) cells, screened and guaranteed for differentiation, in B-ALITM (Bronchial Air Liquid Interface) cell culture.
Sales unit: each -
Human CD4+/CD45RA+ Naive T CellsCatalog #: 4W-202Human CD4+/CD45RA+ Naive T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 5 million cells, cryopreservedSales unit: each
-
TheraPEAK™ MSCBM™ Basal Medium - 1 LCatalog #: BEBP12-934QTheraPEAKTM MSCGMTM Mesenchymal Stem Cell Basal Medium is a GMP-produced, serum-free cell medium without gentamicin and phenol red, 1 L.Sales unit: each
-
TheraPEAK® MSCGMTM Supplement, 5mlCatalog #: BEBP13-935Z5
TheraPEAK&treg; MSCGMTM Mesenchymal Stem Cell Growth Medium Supplement is a GMP-produced, serum-free cell culture medium supplement, 5mL
Sales unit: each -
Fresh Human Leukopak - Mozobil(R) Mobilized (Full Bag)Catalog #: 3Y-300EFresh human leukopheresis product collected from peripheral blood mobilized with Mozobil(R) 20 mg/mL, 1.2mL Single Dose, 1 BagSales unit: each
-
EGMTM -2 MV Microvascular Endothelial Cell Growth Medium-2 BulletKitTMCatalog #: CC-3202
Culture system containing EBMTM-2 Basal Medium (CC-3156) and EGMTM-2 MV Microvascular Endothelial Cell Growth Medium SingleQuotsTM supplements (CC-4147) required for growth of Microvascular Endothelial Cells
Sales unit: kit -
HMVEC-dNeo – Human Dermal Microvascular Endothelial Cells, Neonatal, PooledCatalog #: CC-2516HMVEC-d Neo, Dermal Microvascular Endothelial, Neonatal, PooledSales unit: each
-
HRCE – Human Renal Cortical Epithelial CellsCatalog #: CC-2554
Cryopreserved ampule of Renal Cortical Epithelial Cells (HRCE) containing ≥500,000 cells
Sales unit: each -
D-HCAEC – Diseased Human Coronary Artery Endothelial Cells – Diabetes Type IICatalog #: CC-2922
D-HCAEC, Human Coronary Artery Endothelial Cells, Diabetes T2
Sales unit: Ampule -
D-HPAEC – Diseased Human Pulmonary Artery Endothelial Cells – Diabetes Type ICatalog #: CC-2923
D-HPAEC, Pulmonary Artery Endothelial Cells, Diabetes T1
Sales unit: Ampule
Added to Your Shopping Cart
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
Product Availability by Store Location
Hours